ATE504834T1 - Verfahren und vorrichtung zum nachweis von katzen-immunschwächevirus - Google Patents

Verfahren und vorrichtung zum nachweis von katzen-immunschwächevirus

Info

Publication number
ATE504834T1
ATE504834T1 AT05713662T AT05713662T ATE504834T1 AT E504834 T1 ATE504834 T1 AT E504834T1 AT 05713662 T AT05713662 T AT 05713662T AT 05713662 T AT05713662 T AT 05713662T AT E504834 T1 ATE504834 T1 AT E504834T1
Authority
AT
Austria
Prior art keywords
fiv
animal
immune deficiency
deficiency virus
detecting
Prior art date
Application number
AT05713662T
Other languages
English (en)
Inventor
Randall Groat
Quentin Tonelli
Original Assignee
Idexx Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idexx Lab Inc filed Critical Idexx Lab Inc
Application granted granted Critical
Publication of ATE504834T1 publication Critical patent/ATE504834T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/702Specific hybridization probes for retroviruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/15011Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • G01N2333/15Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT05713662T 2004-02-19 2005-02-16 Verfahren und vorrichtung zum nachweis von katzen-immunschwächevirus ATE504834T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54596604P 2004-02-19 2004-02-19
US58489104P 2004-06-30 2004-06-30
PCT/US2005/004924 WO2005080939A2 (en) 2004-02-19 2005-02-16 Method and device for detecting feline immunodeficiency virus

Publications (1)

Publication Number Publication Date
ATE504834T1 true ATE504834T1 (de) 2011-04-15

Family

ID=34890513

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05713662T ATE504834T1 (de) 2004-02-19 2005-02-16 Verfahren und vorrichtung zum nachweis von katzen-immunschwächevirus

Country Status (8)

Country Link
US (1) US7348136B2 (de)
EP (1) EP1723425B1 (de)
JP (1) JP2007523170A (de)
AT (1) ATE504834T1 (de)
AU (1) AU2005215629B2 (de)
CA (1) CA2556141A1 (de)
DE (1) DE602005027326D1 (de)
WO (1) WO2005080939A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8809004B2 (en) 2010-04-02 2014-08-19 Idexx Laboratories, Inc. Detection of feline immunodeficiency virus

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4629783A (en) 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
US4879212A (en) 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
CA1341439C (en) 1987-08-26 2003-09-23 Niels C. Pedersen Feline t-lymphotropic lentivirus
US5118602A (en) 1987-08-26 1992-06-02 The Regents Of The University Of California Feline T-lymphotropic lentivirus assay
US4900548A (en) 1987-11-13 1990-02-13 Harvard University Use of diethylcarbamazine to enhance antigen-antibody and antigen-host immune cell interactions
JPH0211524A (ja) * 1988-06-29 1990-01-16 Gen Corp:Kk オーエスキー病ワクチンの製造方法及び該ワクチン接種豚と自然感染豚との識別方法
CA1335880C (en) 1988-07-14 1995-06-13 Thomas P. O'connor Detection of an antibody and antigen in an immunoassay
US5219725A (en) 1988-12-05 1993-06-15 Idexx Laboratories Incorporated Monoclonal antibodies to feline-t-lymphotropic lentivirus
US5177014A (en) 1988-12-05 1993-01-05 Idexx Laboratories, Inc. Monoclonal antibodies to feline-T-lymphotropic lentivirus
JP3058685B2 (ja) 1989-05-08 2000-07-04 アイデックス ラボラトリーズ インコーポレーテッド ネコt細胞リンパトロピック レンチウィルスのポリペプチド
FR2669338A1 (fr) * 1990-11-21 1992-05-22 Centre Nat Rech Scient Fragments peptidiques issus de la proteine externe du vif, anticorps antifragments, application de ceux-ci au diagnostic et/ou au traitement de l'immunodeficience feline.
US6228608B1 (en) 1991-02-28 2001-05-08 Aquila Biopharmaceuticals, Inc. Recombinant FIV glycoprotein 160 and P24 gag protein
DE69223250T3 (de) 1991-06-14 2008-02-28 Idexx Laboratories, Inc. Detektion des immunschwäche-virus aus felis
WO1993001304A1 (en) 1991-07-10 1993-01-21 Synbiotics Corporation Synthetic peptides related to fiv-env proteins
US5726010A (en) 1991-07-31 1998-03-10 Idexx Laboratories, Inc. Reversible flow chromatographic binding assay
US5736378A (en) 1991-09-12 1998-04-07 The Scripps Research Institute Molecular cloning and characterization of the feline immunodeficiency virus isolate PPR
DE69333636T2 (de) * 1992-06-16 2005-10-06 Centre National De La Recherche Scientifique Nukleotid- und Peptidsequenzen des Immunschwächevirus der Katze, Isolat WO und Anwendungen der Sequenzen in der Diagnostik und zur Verhinderung der Infektion
GB9215232D0 (en) 1992-07-17 1992-09-02 Pitman Moore Inc Vaccines
GB9219936D0 (en) * 1992-09-21 1992-11-04 Pitman Moore Inc Vaccines
US5462852A (en) 1992-10-28 1995-10-31 The Government Of The United States Of America, As Represented By The Secretary, Dhhs HIV Nucleocapsid protein capture assay and method of use
JPH07159408A (ja) * 1993-12-09 1995-06-23 Biseibutsu Kagaku Kenkyusho:Kk オーエスキー病ウイルス感染抗体識別用抗原
US5576177A (en) 1994-03-09 1996-11-19 St. Jude Children's Research Hospital Bioassay for reverse transcriptase inhibitors
ES2267101T3 (es) 1994-04-29 2007-03-01 PHARMACIA & UPJOHN COMPANY LLC Vacuna contra virus de inmunodeficiencia felina.
FR2721031B1 (fr) 1994-06-09 1996-07-26 Centre Nat Rech Scient Fragment peptidique spécifique du virus de l'immunodéficience féline (VIF) et son utilisation comme réactif de diagnostic.
CA2195753C (en) 1994-07-25 2008-12-16 Ursula-Henrike Wienhues Determination of a specific immunoglobulin using multiple antigens
DE4430998A1 (de) * 1994-07-25 1996-02-01 Boehringer Mannheim Gmbh Metallchelat-markierte Peptide
FR2732346B1 (fr) 1995-03-27 1997-05-30 Centre Nat Rech Scient Proteines mutees, codees par un gene env mute de lentivirus, fragments peptidiques inclus dans lesdites proteines, vecteurs d'expression exprimant lesdites proteines mutees et leurs applications
US5820869A (en) 1995-06-07 1998-10-13 American Home Products Corporation Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
US6300118B1 (en) 1995-06-07 2001-10-09 American Home Products Corporation Plasmids comprising a genetically altered feline immunodeficiency virus genome
US5849303A (en) 1995-06-07 1998-12-15 American Home Products Corporation Recombinant feline Immunodeficiency virus subunit vaccines employing baculoviral-expressed envelope glycoproteins derived from isolate NCSU-1 and their use against feline immunodeficiency virus infection
CA2230029C (en) 1995-08-25 2012-03-27 University Of Florida Multi-subtype fiv vaccines
US6254872B1 (en) 1995-08-25 2001-07-03 University Of Florida Multi-subtype FIV vaccines
US6077662A (en) 1996-11-27 2000-06-20 Emory University Virus-like particles, methods and immunogenic compositions
US6331616B1 (en) 1997-03-05 2001-12-18 North Carolina State University Nucleic acids obtained from the envelope coding region of feline immunodeficiency virus molecular clone designated JSY3
EP0887412B1 (de) * 1997-05-26 2003-10-15 Akzo Nobel N.V. Rekombinanter Birnavirusimpfstoff
FR2769916B1 (fr) 1997-10-17 2000-12-01 Centre Nat Rech Scient Peptides issus du gene env du virus de l'immunodeficience feline et leurs applications immunoprotectrices et vaccinales
FR2771011B1 (fr) 1997-11-17 2000-01-28 Hippocampe Obtention de vaccins destines a prevenir les effets pathogenes associes a une infection retrovirale
JP2001525347A (ja) 1997-12-05 2001-12-11 ザ ユニバーシティ オブ ニュー メキシコ 熱ショックペプチド錯体の精製方法
US6284253B1 (en) 1998-01-29 2001-09-04 Cornell Research Foundation, Inc. Feline immunodeficiency virus (FIV) nucleotide sequence
US6458528B1 (en) 1998-05-15 2002-10-01 Idexx Laboratories, Inc. Diagnosis of feline immunodeficiency virus infection using ENV/GAG polypeptide markers
DE50010240D1 (de) 1999-07-08 2005-06-09 Mologen Forschungs Entwicklung Impfstoff gegen infektionen mit lentiviren, wie dem felinen immunschwäche-virus der katze
AU7855900A (en) 1999-10-04 2001-05-10 University Of Medicine And Dentistry Of New Jersey Methods for identifying rna binding compounds
FR2828687B1 (fr) 2001-08-17 2003-12-12 Hippocampe Nouveaux peptides et leur utilisation comme medicaments contre l'infection par le fiv chez le chat
CA2525641A1 (en) 2003-05-12 2004-11-25 University Of Florida Research Foundation, Inc. Materials and methods for immunizing against fiv infection
JP2007505320A (ja) * 2003-09-11 2007-03-08 アイデックス ラボラトリーズ インコーポレイテッド ネコ免疫不全ウイルスの検出のための方法と装置
EP1709447B1 (de) * 2003-12-18 2009-06-24 Idexx Laboratories, Inc. Verfahren zum nachweis des felinen immunschwächevirus

Also Published As

Publication number Publication date
JP2007523170A (ja) 2007-08-16
CA2556141A1 (en) 2005-09-01
WO2005080939A3 (en) 2005-10-06
US7348136B2 (en) 2008-03-25
DE602005027326D1 (de) 2011-05-19
EP1723425A2 (de) 2006-11-22
EP1723425B1 (de) 2011-04-06
US20050208067A1 (en) 2005-09-22
WO2005080939A2 (en) 2005-09-01
AU2005215629A1 (en) 2005-09-01
AU2005215629B2 (en) 2009-01-29

Similar Documents

Publication Publication Date Title
DE50113548D1 (de) Verfahren zum Nachweis von Influenza A/B-Viren in Speichel
ATE403153T1 (de) Test zum direkten nachweisen einer rs virus bezogenen biologischen zelle in einer körperflüssigkeitsprobe
ATE437886T1 (de) Verfahren und reagentien zum nachweis von endotoxin
DE60041355D1 (de) Verfahren zur detektion von erkrankungen
ATE466108T1 (de) Optoelektronisches detektionssystem
ES2139571T3 (es) Ensayo de hepatitis c que utiliza antigenos recombinantes.
ATE443154T1 (de) Vorrichtung und verfahren zur bestimmung und klassifizierung von chemikalien, partikeln, viren und bakterien in fluiden mittels aptamer
DE602005009819D1 (de) Verfahren zum nachweis von infektionen mit mykobakterien
DE602004021724D1 (de) Verfahren zum nachweis des felinen immunschwächevirus
ATE504596T1 (de) Verfahren und vorrichtung zum nachweis von katzen-immunschwächevirus
ATE504834T1 (de) Verfahren und vorrichtung zum nachweis von katzen-immunschwächevirus
ATE516502T1 (de) Nachweis des westnil-virus
EA200700345A1 (ru) Обогащённое антитело для выявления микобактериальной инфекции, способы применения и диагностические тесты, применяющие такое антитело
JP2005538343A5 (de)
DE602004021829D1 (de) Verfahren zum nachweis des felinen immunschwächevirus
ATE504662T1 (de) Nachweis des bovinen virusdiarrhoe-virus in gewebeproben
DE60131962D1 (de) Verfahren und zusammensetzungen zum nachweis von taenia solium larven mittels eines klonierten antigens
DE60129635D1 (de) Verfahren zur Messung der Dauer eines adäquaten Immungedächtnisses in Haustieren
DK1192469T3 (da) Assay
CA2576902A1 (en) Method and device for detecting feline immunodeficiency virus
RU2001106465A (ru) Способ выявления больных лейкозом крупного рогатого скота животных
ATE515701T1 (de) Verwendung eines bindungsteil exprimierenden virus zur messung von analyten in einer probe
CA2576930A1 (en) Method and device for detecting feline immunodeficiency virus (fiv) comprising the use of peptides derived from the v3 region of the fiv env protein
JP2008505314A5 (de)
JP2008505073A5 (de)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties